Target intelligence / Profile preview

Antigen-presenting cell uptake enhancement

Molecular classification
Other
01

Overview

"Antigen-presenting cell uptake enhancement" refers to strategies or interventions aimed at increasing the efficiency of antigen internalization by APCs such as dendritic cells, macrophages, and B cells. Enhanced uptake is often achieved by targeting specific receptors on APCs (including Fcγ receptors, C-type lectin receptors like DEC-205, or B cell receptors[1][4][5][6]) via engineered delivery platforms or adjuvants. This process results in greater expression of MHC-peptide complexes, costimulatory molecules, and cytokine secretion, collectively boosting the ability of APCs to activate T cells and drive effective immune responses, as used in vaccine and immunotherapy research[1][3][4][5][6]. However, "uptake enhancement" describes a function or therapeutic approach—not a unique molecule or canonical target—and does not refer to a singular receptor, enzyme, or protein.

Other names
antigen uptake by APCsAPC antigen acquisitionAPC antigen internalization
02

Mechanism of action

Enhancement of antigen targeting to uptake receptors (e.g., Fcγ receptors, C-type lectin receptors); Increased uptake via phagocytosis, endocytosis, trogocytosis, or receptor-mediated internalization by APCs; Enhanced antigen presentation leading to T cell priming (via upregulated MHC, costimulatory molecules, and cytokines).

03

Biological functions

Immune responseAntigen processing and presentationT cell activation
04

Disease associations

InfectionCancerInflammationOther
05

Safety considerations

Non-specific/inappropriate activation of APCs can lead to unwanted immune responses (e.g., excessive inflammation, autoimmunity)Limited specificity when uptake enhancement is not targeted, risking systemic immune activation
06

Interacting drugs

Adjuvants

1 more in the full profile.

07

Biomarkers

APC expression levels of MHC-IICD86CD40specific uptake receptors

Beyond the preview

Go deeper on Antigen-presenting cell uptake enhancement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell uptake enhancement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call